Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04170933
Other study ID # XJTU1AF-CRF-2015-001-4
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 1, 2019
Est. completion date December 31, 2022

Study information

Verified date April 2022
Source First Affiliated Hospital Xi'an Jiaotong University
Contact Yi Lv, MD,phD
Phone 86-29-85323900
Email luyi169@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Biliary stricture is a common complication after end-to-end biliary anastomosis, especially after liver transplantation. This study is designed to investigate the safety and efficacy of magnetic recanalization technique, a newly clinical method, for treating biliary anastomotic stricture.


Description:

Biliary anastomotic stricture is a common complication of after end-to-end biliary anastomosis. Magnetic recanalization is a promising way to establish connection of biliary tract after stenosis or completed obstruction. This study is designed to investigate the safety and efficacy of magnetic recanalization among patients with severe biliary stricture after biliary anastmosis. Patients who failed to undergo stent placement with endoscopic retrograde cholangiopancretography (ERCP) would be enrolled for magnetic recanalization treatment. Magnetic treatment will be implemented by several steps. Firstly, placement of one magnet through the sinus of percutaneous transhepatic cholangio drainage (PTCD) in upper part of the bile duct; Second, introduction of another magnet via ERCP into the distal part of the bile duct, and making them be mated together; Third, after necrosis of the tissue between the two magnets, the magnets will drop off and be taken out together through the thread connected with them out of the mouth. Last, a plastic stent should be placed in the bile duct for a lasting support. The time of recanalization (drop off of the magnets), and adverse events (e.g. fever, melena, nausea, vomiting, anorexia, hematemesis, abdominal pain, and gastrointestinal bleeding) will be recorded, and each patient will be followed up for long-term outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - 1. Age = 18 years old and =65 years old - 2. patients with biliary stricture after end-to-end biliary anastomosis Exclusion Criteria: - 1. Pregnant woman - 2.Have a history of cardiovascular disease, including coronary heart disease (angina pectoris, myocardial infarction, coronary angiogenesis or electrocardiographic abnormal Q wave (ECG)), stroke (ischemic or hemorrhagic, including transient ischemic attack) - 3. Severe lung diseases such as COPD and asthma - 4. Patients with acute infection or inflammation (i.e. pneumonia) - 5. Any other medical condition considers the longest survival time to be less than 2 years - 7. Immunodeficiency or HIV positive - 8. No autonomy, inability to participate in follow-up - 9. Illiterate

Study Design


Intervention

Procedure:
Magnetic recanalization
Establish a percutaneous transhepatic cholangio drainage (PTCD) fistula. Perform endoscopic sphincterotomy (EST). Place one magnet above the stricture through the PTCD fistula. Introduce another magnet below the stricture through the common bile duct with ERCP. Place the magnets at the appropriate point to attract each other. The patient will be strictly followed, and the magnets will be taken out out of the mouth by the thread connected with the magnets. A plastic stent will be placed in the bile duct for lasting support.

Locations

Country Name City State
China First Affiliated Hospital of Xian JiaotongUniversity Xi'an Shaanxi

Sponsors (1)

Lead Sponsor Collaborator
First Affiliated Hospital Xi'an Jiaotong University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time duration of biliary recanalization, d (days) Time period for recanalization of the bile duct From date of treatment (two magnets mated together) until the date of drop-off or the two magnets from the biliary tract or date of death from any cause, whichever came first, assessed up to 12 months
Secondary Incidence of stricture recurrence Incidence of biliary stricture recurrence after magnetic recanalization treatment From date of drop-off of the two magnets until the date of biliary stricture recurrence or end of the follow-up or date of death from any cause, whichever came first, assessed up to 12 months
See also
  Status Clinical Trial Phase
Completed NCT02971579 - A Register on the Quality of ERCP and Training of Endoscopists in Italy
Recruiting NCT02310230 - An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy N/A
Not yet recruiting NCT01900938 - Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During ERCP N/A
Completed NCT00370344 - Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease Phase 2/Phase 3
Suspended NCT04559867 - Fistulotomy as the Primary Cannulation Technique for All Patients Undergoing ERCP: A Randomized, Controlled Trial N/A
Enrolling by invitation NCT04572711 - Prospective Evaluation of Biliary Tissue Sampling With ERCP
Recruiting NCT01715220 - Treatment of Suspected Cholelithiasis With Nitroglycerin Phase 2
Recruiting NCT05249400 - Effect of Off-site Assistance on Success Rate of Selective Cannulation During hands-on ERCP Training N/A
Completed NCT02287194 - SpyGlass Direct Visualization System Clinical Registry in China
Active, not recruiting NCT03190343 - Assessment of Cholangio-pancreatoscopy for the Diagnosis and the Treatment of Biliary and Pancreatic Diseases
Withdrawn NCT00672698 - Evaluation of Surgical Risk in Elderly Patients Submitted to Elective Surgery N/A
Completed NCT00751998 - Spy II Clinical Registry
Completed NCT04604652 - Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis Phase 2
Completed NCT02353286 - Endoscopic Treatment of Benign Biliary Strictures and Cystic Duct Leakages With a Novel Biodegradable Biliary Stent N/A
Recruiting NCT03074708 - Application of 3D Visualization and 3D Printing in the Hepatobiliary and Pancreatic Surgery N/A
Not yet recruiting NCT06276153 - Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer
Withdrawn NCT03678480 - A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC) Phase 2
Completed NCT04115696 - Biodegradable Stent Implantation in Biliary Benign Strictures.
Recruiting NCT04391426 - Analysis of Biliary Microbiota in Hepatobiliopancreatic Diseases Compared to Healthy People [MICROBILIO]
Completed NCT01350037 - Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP) Phase 4